Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acurx Pharmaceuticals, Inc.ACXP · Entity 8195 | Director | April 20, 2026 | April 22, 2026 |
| OptiNose, Inc.OPTN · Entity 79464 | Director | June 08, 2022 | June 09, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acurx Pharmaceuticals, Inc.
Report date April 20, 2026 · Filed April 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.36 · Expires 2036-04-20 | Direct | 2,150 |
Reported balance
After 2026-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-20 · Grant · Acquired 2,150 · Balance 2,150 F1: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027.
OptiNose, Inc.
Report date June 08, 2022 · Filed June 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2032-06-08 | Direct | 32,000 |
Reported balance
After 2022-06-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-08 · Grant · Acquired 32,000 · Balance 32,000 F1: The option vests and becomes exercisable on the earlier of (i) June 8, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable on the earlier of (i) June 8, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
JOHNSON & JOHNSON
Report date May 28, 2008 · Filed May 30, 2008
Section 16 reporting ended · disclosed 2008-05-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 18,646 |
Reported balance
After 2008-05-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2008-05-28 · Exercise / conversion · Acquired 2,100 · Balance 18,646 F1: Adjusted to reflect two-for-one stock split in 2001. F2: Includes 170 shares held under Issuer's Dividend Reinvestment Plan. |
| CommonSEC Table I · non-derivative | Direct | 83,731 |
Reported balance
After 2008-05-28 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2008-05-28 · Exercise / conversion · Acquired 65,085 · Balance 83,731 |
| CommonSEC Table I · non-derivative | Direct | 75,982 |
Reported balance
After 2008-05-28 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2008-05-28 · Sale · Disposed 7,749 · Balance 75,982 |
| CommonSEC Table I · non-derivative | Direct | 49,056 |
Reported balance
After 2008-05-28 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2008-05-28 · Sale · Disposed 26,926 · Balance 49,056 |
| CommonSEC Table I · non-derivative | Direct | 23,171 |
Reported balance
After 2008-05-28 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2008-05-28 · Sale · Disposed 25,885 · Balance 23,171 |
| CommonSEC Table I · non-derivative | Direct | 22,746 |
Reported balance
After 2008-05-28 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2008-05-28 · Sale · Disposed 425 · Balance 22,746 |
| CommonSEC Table I · non-derivative | Direct | 18,646 |
Reported balance
After 2008-05-28 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2008-05-28 · Sale · Disposed 4,100 · Balance 18,646 |
| CommonSEC Table I · non-derivative | Indirect401 (k) and ESOP Savings Plans | 2,845 |
Reported balance
After 2008-04-30 transaction · row 8
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 8 · 2008-04-30 · Other · Acquired 98 · Balance 2,845 F3: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (4/30/2008). |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.39 · Expires 2009-10-06 | Direct | 0 |
Reported balance
After 2008-05-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2008-05-28 · Exercise / conversion · Disposed 2,100 · Balance 0 F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1: Adjusted to reflect two-for-one stock split in 2001. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.20 · Expires 2011-03-20 | Direct | 0 |
Reported balance
After 2008-05-28 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2008-05-28 · Exercise / conversion · Disposed 65,085 · Balance 0 F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Adjusted to reflect two-for-one stock split in 2001.
F2: Includes 170 shares held under Issuer's Dividend Reinvestment Plan.
F3: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (4/30/2008).
F4: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2026 Filed Apr 22, 2026 16:19 UTC | Acurx Pharmaceuticals, Inc. ACXP · Entity 8195 | GrantStock Option · Derivative | 2,150 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001104659-26-046837 · tm2612397-4_4seq1.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,150 Underlying: Common Stock · 2,150 shares Expires 2036-04-20 F1 · shares: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 16:32 UTC | Acurx Pharmaceuticals, Inc. ACXP · Entity 8195 | PurchaseWarrants for Common Stock · Derivative | 24,631 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001104659-25-002054 · tm252665-6_4seq1.xml · derivative · entry 2 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,631 Underlying: Common Stock · 24,631 shares Expires 2030-01-07 F2 · shares: Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 16:32 UTC | Acurx Pharmaceuticals, Inc. ACXP · Entity 8195 | PurchaseCommon Stock | 24,631 | $1.02 | $25,000.47 |
DisclosureSEC source: 0001104659-25-002054 · tm252665-6_4seq1.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,708 F1 · shares: Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 16:15 UTC | Acurx Pharmaceuticals, Inc. ACXP · Entity 8195 | GrantStock Option · Derivative | 12,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001104659-24-072815 · tm2417510-5_4seq1.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 17, 2025. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 17:45 UTC | Acurx Pharmaceuticals, Inc. ACXP · Entity 8195 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001104659-23-072368 · tm2319012-1_4seq1.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-15 F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 15, 2024. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 10:13 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001494650-22-000054 · wf-form4_165478400915503.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 8, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 16:15 UTC | Acurx Pharmaceuticals, Inc. ACXP · Entity 8195 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $6.18 | $0.00 |
DisclosureSEC source: 0001104659-21-089420 · tm2121302d5_4seq1.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 15:11 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $0.00 Strike: $3.54 | $0.00 |
DisclosureSEC source: 0001494650-21-000069 · wf-form4_162335228412356.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,439 Underlying: Common Stock · 14,439 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 9, 2022 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2022 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| May 10, 2021 Filed May 11, 2021 14:27 UTC | OptiNose, Inc. OPTN · Entity 79464 | PurchaseCommon Stock | 10,000 | $2.99 | $29,900.00 |
DisclosureSEC source: 0001494650-21-000058 · wf-form4_162075765816981.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,230 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.97 to $3.00. The price reported above reflects the weighted average purchase price. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 07:53 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $5.65 Strike: $5.65 | $81,580.35 |
DisclosureSEC source: 0001494650-20-000067 · wf-form4_159196277754809.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,878 Underlying: Common Stock · 14,439 shares Expires 2030-06-09 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 10, 2021 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2021 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 07:07 UTC | OptiNose, Inc. OPTN · Entity 79464 | PurchaseCommon Stock | 200 | $5.53 | $1,105.00 |
DisclosureSEC source: 0001494650-20-000033 · wf-form4_158375199918413.xml · nonDerivative · entry 3 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,230 Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 07:07 UTC | OptiNose, Inc. OPTN · Entity 79464 | PurchaseCommon Stock | 2,000 | $5.56 | $11,124.60 |
DisclosureSEC source: 0001494650-20-000033 · wf-form4_158375199918413.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,030 Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 07:07 UTC | OptiNose, Inc. OPTN · Entity 79464 | PurchaseCommon Stock | 6,500 | $5.75 | $37,375.00 |
DisclosureSEC source: 0001494650-20-000033 · wf-form4_158375199918413.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,030 Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 14:42 UTC | OptiNose, Inc. OPTN · Entity 79464 | PurchaseCommon Stock | 6,100 | $8.22 | $50,142.00 |
DisclosureSEC source: 0001494650-19-000103 · wf-form4_157592054997623.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 10:49 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $6.60 Strike: $6.60 | $95,297.40 |
DisclosureSEC source: 0001494650-19-000055 · wf-form4_156017814379309.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,439 Underlying: Common Stock · 14,439 shares Expires 2029-06-05 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 6, 2020 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2020 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| December 12, 2018 Filed Dec 12, 2018 17:06 UTC | OptiNose, Inc. OPTN · Entity 79464 | PurchaseCommon Stock | 6,430 | $7.89 | $50,732.70 |
DisclosureSEC source: 0001494650-18-000117 · wf-form4_154465238831767.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,430 Read SEC document |
| June 11, 2018 Filed Jun 11, 2018 17:26 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $22.50 Strike: $22.50 | $324,877.50 |
DisclosureSEC source: 0001494650-18-000065 · wf-form4_152875239529406.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,439 Underlying: Common Stock · 14,439 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 7, 2019 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2019 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| October 12, 2017 Filed Oct 16, 2017 12:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 43,318 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-17-062320 · a4.xml · derivative · entry 1 Scodari Joseph C · CIK 0001319892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,318 Underlying: Common Stock · 43,318 shares Expires 2027-10-11 F1 · derivative.exercise_date: The option vests and becomes exercisable over a three-year period commencing on October 12, 2017. Thirty-three percent (33%) of the option vests and becomes exercisable on October 12, 2018, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer. Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 65,085 | Not disclosed Strike: $52.20 | Not disclosed |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · derivative · entry 10 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,085 shares Expires 2011-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F4 · price: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,100 | Not disclosed Strike: $47.39 | Not disclosed |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · derivative · entry 9 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,100 shares Expires 2009-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1 · derivative.exercise_price: Adjusted to reflect two-for-one stock split in 2001. F4 · price: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 4,100 | $64.73 | $265,393.00 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 7 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,646 Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 425 | $64.74 | $27,514.50 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 6 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,746 Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 25,885 | $64.75 | $1,676,053.75 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 5 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,171 Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 26,926 | $64.76 | $1,743,727.76 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 4 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,056 Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 7,749 | $64.77 | $501,902.73 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 3 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,982 Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 65,085 | $52.20 | $3,397,437.00 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 2,100 | $47.39 | $99,519.00 |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted to reflect two-for-one stock split in 2001. F2 · balance_after: Includes 170 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
| April 30, 2008 Filed May 30, 2008 18:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 98 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000089 · edgar.xml · nonDerivative · entry 8 Scodari Joseph C · CIK 0001319892 · Retired Exec Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,845 F3 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (4/30/2008). Read SEC document |
| February 14, 2008 Filed Feb 15, 2008 22:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon | 2,266 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000051 · edgar.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,546 F1 · price: Awarded under Issuer's Long-Term Incentive Plan. F2 · balance_after: Includes 170 shares held under Issuer's Dividend Reinvestment Plan. Read SEC document |
| January 31, 2008 Filed Feb 15, 2008 22:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 42 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000051 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,747 F3 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (1/31/2008). Read SEC document |
| January 25, 2008 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,850 | Not disclosed Strike: $53.93 | Not disclosed |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · derivative · entry 7 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,850 shares Expires 2014-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1 · price: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document |
| January 25, 2008 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,915 | Not disclosed Strike: $52.20 | Not disclosed |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · derivative · entry 6 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,915 shares Expires 2013-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1 · price: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document |
| January 25, 2008 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,700 | Not disclosed Strike: $57.30 | Not disclosed |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · derivative · entry 5 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,700 shares Expires 2012-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1 · price: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document |
| January 25, 2008 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 1,850 | $53.93 | $99,770.50 |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · nonDerivative · entry 3 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2008 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 1,915 | $52.20 | $99,963.00 |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2008 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 1,700 | $57.30 | $97,410.00 |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2007 Filed Jan 29, 2008 14:26 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 162 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000020 · edgar.xml · nonDerivative · entry 4 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,705 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (12/30/2007). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (12/30/2007). Read SEC document |
| December 30, 2007 Filed Feb 13, 2008 22:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 162 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-08-000032 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,705 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (1/31/2008). Read SEC document |
| February 16, 2007 Filed Feb 21, 2007 23:23 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon | 1,717 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000041 · edgar.xml · nonDerivative · entry 1 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,645 F1 · price: Awarded under Issuer's Executive Bonus Plan. Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 22:37 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 9,144 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-07-000025 · edgar.xml · derivative · entry 4 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,144 Underlying: Common Stock · 9,144 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock. F4 · derivative.expiration_date: The Restricted Share Units vest three years after date of grant. Read SEC document |
| February 12, 2007 Filed Feb 15, 2007 22:37 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Option (Right to Buy) · Derivative | 109,723 | $0.00 Strike: $65.62 | $0.00 |
DisclosureSEC source: 0000200406-07-000025 · edgar.xml · derivative · entry 3 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,723 Underlying: Common Stock · 109,723 shares Expires 2017-02-10 F2 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| January 31, 2007 Filed Feb 15, 2007 22:37 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 42 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-07-000025 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 2,543 F1 · price: Shares held under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/31/2007). Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 58,000 | Not disclosed Strike: $50.69 | Not disclosed |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · derivative · entry 10 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,000 shares Expires 2010-11-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. F1 · derivative.exercise_price: Adjusted to reflect two-for-one stock split in 2001. F3 · price: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 9,400 | $68.50 | $643,900.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 8 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,928 Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 700 | $68.51 | $47,957.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 7 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,328 Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 6,800 | $68.52 | $465,936.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 6 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,028 Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 7,800 | $68.53 | $534,534.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 5 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,828 Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 9,800 | $68.54 | $671,692.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 4 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,628 Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 13,800 | $68.55 | $945,990.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 3 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,428 Read SEC document |
| October 24, 2006 Filed Oct 26, 2006 15:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 9,700 | $68.56 | $665,032.00 |
DisclosureSEC source: 0000200406-06-000136 · edgar.xml · nonDerivative · entry 2 Scodari Joseph C · CIK 0001319892 · Executive Committee Member 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,228 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.